262
Views
2
CrossRef citations to date
0
Altmetric
Brief Report

In-silico study on viability of MXenes in suppressing the coronavirus infection and distribution

, , , , &
Pages 11460-11466 | Received 30 Jan 2021, Accepted 15 Jul 2021, Published online: 30 Jul 2021
 

Abstract

Herein, based on the paramount importance of combating emerging diseases, through employing a detailed in-silico study, the possibility of using MXenes in suppressing the coronavirus infection was elucidated. To this end, first, interactions of MXene nanosheets (Mn2C, Ti2C, and Mo2C) and spike protein (SP), the main infecting portion of the COVID-19, were investigated. It was found that the modeled MXenes were effective in attracting the SP, so that they can be exploited in filtering the coronavirus. In addition, the effect of the MXenes on the SP structure was assessed which demonstrated that the secondary structure of the SP could be changed. Therefore, the post-interactions of the SP/ACE2 (receptor of coronavirus in the body) could be interrupted, declaring the lower chance of coronavirus infecting. The in-silico studies revealed that the MXenes not only can be used to adsorb and hinder the distribution of the coronavirus but also affect the SP structure and the SP/ACE2 interactions to interrupt the COVID-19 threat. Therefore, MXenes can be exploited with simultaneous roles in physical inhibition and reactive weakening of the COVID-19. In this regard, the Mn2C nanosheet was well suited, which is suggested as a promising candidate to combat the coronavirus.

Graphical Abstract

Communicated by Ramaswamy H. Sarma

Disclosure statement

No potential conflict of interest was reported by the author(s).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.